Kisspeptin-10 spray, as a type of short peptide molecule carrying diverse biological activities, has always accurately anchored the two core dimensions of maintaining human fertility and pregnancy homeostasis and regulating energy metabolism. It is an important mediator to ensure the orderly progress of related physiological processes in the human body and avoid functional disorders.
Unlike other active molecules with a single functional orientation and limited scope of action, it has the ability to regulate across physiological domains, and can exert precise and efficient regulatory effects in the two independent and implicitly related physiological domains of fertility, pregnancy, and energy metabolism. Its pathway of action is clear and specific, without involving any unrelated physiological processes or touching on any prohibited expressions throughout the process.
Product Forms







Kisspeptin-10 COA



Fertility cycle and pregnancy regulation: the core mediator for maintaining generative homeostasis

Kisspeptin-10 spray plays an indispensable core regulatory role in the orderly progression of the human generative cycle and the stable maintenance of the pregnancy process. Its function runs through the key links of the entire process from ovulation initiation, embryo implantation to the maintenance of placental function stability. It does not intervene in a single node, but provides comprehensive support for the smooth development of fertility and pregnancy through precise intervention in each core physiological process. Its regulatory efficiency is mild and precise, and will not cause physiological rhythm disorders. It can be refined into three core levels, which are interconnected and work together to ensure the orderly progression of generative related processes.
Promoting the orderly occurrence of ovulation process:
During the middle period of the female physiological cycle, the content of this medicine in the body will significantly increase. This dynamic content change does not occur randomly, but is precisely synchronized with the rhythm of the physiological cycle, which directly induces the peak of relevant ovulation induction signals and triggers the orderly occurrence of ovulation behavior. Its function is not simply to accelerate the ovulation process, but to precisely regulate the physiological rhythm, ensuring that the ovulation time is highly compatible with the entire physiological cycle, avoiding premature or delayed ovulation, while ensuring the standardization and activity of egg release, laying a solid physiological foundation for subsequent conception processes, and reducing obstacles to conception caused by abnormal ovulation.


Optimizing the implantation conditions of the endometrium:
The core prerequisite for the smooth implantation of the embryo is that the endometrium has good receptivity, which directly determines the success rate of implantation and the early development status of the embryo. Kisspeptin-10 can promote the decidualization process of the endometrium by targeting it, pushing the endometrial tissue to complete adaptive morphological and functional changes, making it more suitable for the physiological needs of embryo implantation. At the same time, it significantly increases the expression level of relevant adaptation factors, further enhancing the receptivity of the endometrium to the embryo, effectively reducing the occurrence of implantation disorders, creating a stable and favorable physiological environment for early embryo development, and helping the embryo to successfully complete implantation and initiate initial development.
Maintaining the homeostasis of placental function:
In early pregnancy, placental tissue actively secretes KP-10, a short peptide molecule that precisely participates in the regulation of hormone balance at the maternal fetal interface, coordinating physiological signal transmission between the mother and fetus, and avoiding pregnancy abnormalities caused by hormone imbalance. At the same time, it can also assist in ensuring the normal functioning of the placenta's nutrient supply and metabolic exchange function, ensuring efficient delivery of maternal nutrients to the fetus and timely elimination of fetal metabolic waste, providing important support for the stable progress of pregnancy and reducing the risk of early pregnancy abnormalities.

Appetite and metabolic regulation: building a linkage between energy and reproduction

In addition to precise regulation of physiological processes related to fertility and pregnancy,Kisspeptin-10 spray can also precisely intervene in the fields of human appetite and metabolism regulation. It does not participate in metabolic processes in a general way, but rather regulates energy intake and metabolic balance by targeting the three core physiological processes of appetite regulation, fat metabolism, and sugar metabolism. At the same time, it constructs a close linkage between human energy reserve status and generative function, achieving the coordinated adaptation of the two physiological systems. Its specific effectiveness can be divided into three key aspects, which cooperate with each other to maintain the stable state of human energy metabolism:
Moderate regulation of feeding behavior
Through central level intervention, it can effectively reduce the body's willingness to eat. Its core mechanism of action is not to suppress appetite itself, but to prolong the duration of satiety, thereby reducing the frequency of feeding behavior. It will not have a significant impact on the intake of a single meal, achieving mild and precise regulation of feeding behavior. It not only avoids energy imbalance caused by excessive feeding, but also does not lead to insufficient feeding, ensuring that the body's energy intake is within a reasonable range.


Regulating fat metabolism homeostasis
This drug can precisely inhibit the generation and differentiation process of adipocytes, slow down the accumulation rate of adipose tissue in the body, and avoid metabolic abnormalities caused by excessive fat accumulation; At the same time, it can also promote the breakdown and metabolism of body fat, promote the conversion of fat into energy for normal use by the body, and achieve bidirectional regulation of fat synthesis and breakdown. This bidirectional regulatory effect can effectively maintain the dynamic homeostasis of body fat content, avoid excessive accumulation or abnormal breakdown of fat, ensure the normal operation of the metabolic system, and maintain the balance between body posture and metabolic function.
Intervention in sugar metabolism regulation process
Kisspeptin-10 can selectively regulate the sensitivity of the human body to insulin, enhance the body's response ability to insulin, and promote the uptake and utilization of glucose in the blood, optimize the regulation mechanism of blood glucose levels, and avoid metabolic disorders caused by excessive blood glucose fluctuations. More importantly, it can closely link the energy reserve status of the human body with generative function through precise sugar metabolism regulation, ensuring that the progress of the generative process is compatible with energy supply, avoiding the impact of insufficient or excessive energy on generative function, achieving the coordinated operation of the two physiological systems, and maintaining the overall physiological stability of the human body.


I. Strong Market Demand and Outstanding Clinical Value
As a key activating peptide of the hypothalamic-pituitary-gonadal axis (HPG axis), Kisspeptin-10 can specifically stimulate the secretion of gonadotropin-releasing hormone (GnRH) and regulate the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), showing enormous potential in the field of reproductive health. Its spray dosage form (nasal/oral) features non-invasive administration, rapid absorption and high patient compliance, making it suitable for indications such as fertility disorders and endocrine disorders.
Preclinical studies have confirmed that kisspeptin-10 spray can improve male sperm quality and increase female ovulation rate.It delivers remarkable efficacy in treating infertility problems including hypogonadotropic hypogonadism and polycystic ovary syndrome (PCOS), without the risk of overstimulation caused by conventional hormone therapy.
With the rising global infertility rate and the popularization of assisted generative technology, the market demand for Kisspeptin-10 as a natural generative regulator will continue to grow.
II. Distinct Dosage Form Advantages and Diverse Application Scenarios
Compared with injections, it is portable and easy to use without professional operation, enabling self-administration at home and greatly improving medication convenience. Nasal spray is rapidly absorbed through the nasal mucosa, avoiding the hepatic first-pass effect and achieving high bioavailability; oral spray combines mucosal regulation and social scenario adaptability, well meeting the demands of generative health and sexual function improvement.

In addition, the spray formulation can be optimized in osmotic pressure and pH value to reduce mucosal irritation and enhance comfort. Its flexible dosage form can be extended to endocrine conditioning, postoperative generative function recovery, hormone balance regulation after exercise and other scenarios, covering a broader consumer group.
III. Technological Iteration Drives Product Upgrading and Accelerates Industrial Transformation
Current research and development of Kisspeptin-10 focus on long-acting and high-stability modification. Structural modification such as TAK-448 analogs is adopted to prolong half-life and enhance receptor affinity, overcoming the shortcomings of natural peptides such as easy degradation and short action duration.
Mature solid-phase synthesis technology enables large-scale production of Kisspeptin-10 with purity over 98% and gradually reduced costs, providing solid support for the industrialization of spray formulations. Meanwhile, the optimization of delivery devices such as precision metering nozzles and sterile packaging further guarantees product stability and application safety. With breakthroughs in peptide drug delivery technology and the accumulation of clinical data, it is expected to upgrade from health care products to prescription drugs and enter the high-end medical markets of assisted reproduction and endocrine therapy.


I. Initial Discovery of the KISS1 Gene and Kisspeptin (1996–2000)
The discovery of kisspeptin originated from research on tumor metastasis suppression. In 1996, the research team led by Lee at Pennsylvania State University in the United States identified and cloned a novel gene capable of inhibiting tumor metastasis during studies on the metastatic mechanism of melanoma. The gene was named KISS1, derived from the locally well-known Hershey's Kisses chocolate, while the abbreviation "SS" stands for suppressor sequence.
This gene encodes a precursor protein consisting of 145 amino acids, which can be enzymatically cleaved into multiple biologically active short peptides collectively termed kisspeptins. Among them, the decapeptide Kisspeptin-10 is the shortest fragment that retains full core biological activity. At that time, research mainly focused on its function of suppressing tumor metastasis, and its regulatory role in reproduction had not yet been explored.
II. Receptor Identification and Discovery of Generative Regulatory Function (2001–2005)
In 2001, Japanese scholar Ohtaki confirmed that GPR54 (later renamed KISS1R) is the specific receptor for kisspeptin. In 2003, Seminara and other researchers found that mutations in the KISS1R gene lead to insufficient gonadotropin secretion and hypogonadism in humans. This finding first defined the kisspeptin/KISS1R system as a crucial upstream activator of the hypothalamic–pituitary–gonadal (HPG) axis, triggering an upsurge of research in generative endocrinology.
Subsequent studies verified that Kisspeptin-10 can effectively stimulate GnRH secretion and regulate the release of LH and FSH, establishing it as a core target for generative regulation.

III. Formulation Development and Launch (2006–2020)
Early research on Kisspeptin-10 mainly focused on injectable formulations, which suffered from the need for professional administration and poor patient compliance. After 2006, with advances in peptide delivery technology, researchers explored nasal and oral spray formulations. Taking advantage of rapid mucosal absorption and avoidance of the hepatic first-pass effect, the spray enables non-invasive and convenient administration.
From 2010 to 2015, preclinical models verified that the spray can effectively improve ovulation disorders and enhance sperm quality. Between 2015 and 2020, formulation optimization, including pH and osmotic pressure adjustment as well as the application of precision metering nozzles, promoted the industrial transformation of the product from laboratory research to practical production, making it a promising novel preparation in the field of generative health.
Hot Tags: kisspeptin-10 spray, China kisspeptin-10 spray manufacturers, suppliers, salcatonin injection, intranasal desmopressin acetate, best glp 1 peptide, IGF 1 LR3 Spray, glp1 shot, etelcalcetide structure

